{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/6214f04174d82e00145af407/66d7d17491ae4d209b5a2546?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"How Real-World Evidence can help tackle the global burden of diabetes and chronic kidney disease","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/6214f04174d82e00145af407/1733310547987-81d0ffcb-5278-49a4-ac72-fbbc9587053d.jpeg?height=200","description":"<p>Data from the IDF Diabetes Atlas Report on diabetes and kidney disease released in 2023,&nbsp;indicate that approximately 30 to 40% of people living with diabetes develop CKD. Furthermore, over the last 20 years, CKD due to type 2 diabetes has increased worldwide by about 74%. In this episode of D-Talk, host <strong>Phyllisa Deroze</strong> welcomes Professors <strong>Mustafa Arici</strong> and <strong>Ruben Silva Tinoco</strong> to explore how the iCaReMe registry can bridge gaps in early diagnosis and prevent diabetes-related kidney complications.</p><p>&nbsp;</p>","author_name":"International Diabetes Federation"}